Clarametyx 2020-06: Efficacy of Novel Antibody(s) in the Rodent Models of Bacterial Infection

Project Details

StatusFinished
Effective start/end date21/09/2020/09/21

Funding

  • Clarametyx Biosciences, Inc.: $121,924.22